Sep 5, 2014 6:30 am EDT VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference
Aug 13, 2014 6:30 am EDT VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials
Apr 24, 2014 6:30 am EDT VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation
Mar 17, 2014 8:30 am EDT New VolitionRx Study Data Demonstrates NuQ(R) Assays' High Detection Rate of Prostate Cancer and the Ability to Distinguish Between Prostate and Colorectal Cancer
